| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 143.2690 | 192.1760 | 346.4740 |
| Cost of Revenue
|
0 | 0 | -38.0190 | -457.8160 | -949.0220 |
|
Gross Profit
|
0 | 0 | 105.2500 | -265.6400 | -602.5480 |
| Selling, General and Administrative Expenses
|
-271.9540 | -295.5390 | -555.5150 | -1,267.8050 | -2,115.2150 |
|
Research and Development Expenses
|
-2.0650 | -2.1900 | -6.2330 | -101.4090 | -203.7510 |
|
Operating Income/Expenses
|
-274.0190 | -297.7290 | -561.7480 | -1,369.2140 | -2,318.9660 |
|
Total Operating Profit/Loss
|
-274.0190 | -297.7290 | -456.4980 | -1,634.8540 | -2,921.5140 |
| Total Net Finance Income/Expense
|
-40.6190 | -27.3280 | -90.9430 | -103.7410 | -69.6860 |
| Irregular Income/Expenses
|
-791.0690 | -791.0690 | -539.3170 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
0 | 0 | 0.0040 | 77.1060 | 394.9520 |
|
Non-Operating Income/Expenses, Total
|
-831.6880 | -818.3970 | -630.2560 | -26.6350 | 325.2660 |
|
Pretax Income
|
-1,105.7070 | -1,116.1260 | -1,086.7540 | -1,661.4890 | -2,596.2480 |
|
Provision for Income Tax
|
195.9580 | 195.9580 | 124.3700 | -34.9500 | -67.5030 |
|
Net Income from Continuing Operations
|
-909.7490 | -920.1680 | -962.3840 | -1,696.4390 | -2,663.7510 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-909.7490 | -920.1680 | -962.3840 | -1,696.4390 | -2,663.7510 |
|
Net Income after Non-Controlling/Minority Interests
|
-909.7490 | -920.1680 | -962.3840 | -1,696.4390 | -2,663.7510 |
|
Net Income Available to Common Stockholders
|
-909.7490 | -920.1680 | -962.3840 | -1,696.4390 | -2,663.7510 |
|
Diluted Net Income Available to Common Stockholders
|
-909.7490 | -920.1680 | -962.3840 | -1,696.4390 | -2,663.7510 |
| Basic EPS
|
-0.02 | -0.02 | -0.02 | -0.03 | -0.05 |
| Diluted EPS
|
-0.02 | -0.02 | -0.02 | -0.03 | -0.05 |
|
Basic Weighted Average Shares Outstanding
|
48,826.8640 | 48,826.8640 | 48,826.8640 | 48,826.8640 | 48,852.2040 |
|
Diluted Weighted Average Shares Outstanding
|
48,826.8640 | 48,826.8640 | 48,826.8640 | 48,826.8640 | 48,852.2040 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,065.0880 | -1,088.7980 | -995.8110 | -1,557.7480 | -2,526.5620 |
|
EBITDA
|
-1,061.5080 | -1,078.0560 | -981.4880 | -1,557.7480 | -2,500.9190 |
|
Normalized EBITDA
|
-270.4390 | -322.7960 | -442.1710 | -1,557.7480 | -2,282.8900 |
|
Normalized Income
|
-121.8530 | -161.7639 | -423.0670 | -1,696.4390 | -2,491.5081 |
|
Total Unusual Items
|
791.0690 | 755.2600 | 539.3170 | 0 | 218.0290 |
|
Total Unusual Items Excluding Goodwill
|
17.9040 | -17.9050 | 0 | 0 | 218.0290 |
|
Tax Effect of Unusual Items
|
3.1730 | -3.1441 | 0 | 0 | 45.7861 |
12/31/2022 - 3/19/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade